ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 2296 - 2310 of 5996 products
dMed Biopharma, a China, US, EU Clinical CRO, Raises $50 Million
$5.00
Available
Shaanxi Micot Raises $16 Million for Bispecific Polypeptide Candidates
$5.00
Available
Chengdu's HitGen Partners with Galapagos for Drug Discovery
$5.00
Available
San Diego's Ansun Bio Closes $80 Million B Round from China Investors for Novel Antiviral
$5.00
Available
Luqa Pharma Approved to Market Adare Diarrhea Treatment in China
$5.00
Available
CanSino to Add Shanghai Star Board IPO to Hong Kong Listing
$5.00
Available
I-Mab Approved for Two China Trials of Multiple Myeloma Treatment
$5.00
Available
BJ Bio Selects CMAB for CMC and Manufacturing of Cancer mAb
$5.00
Available
Harbour BioMed Completes China Phase II Trial of Dry Eye Treatment
$5.00
Available
Kangpu Completes Phase I Trial of Cancer Immunomodulator
$5.00
Available
China Grand Pharma Pays $30 Million for Majority Stake in US-Based OncoSec
$5.00
Available
Innovent and Chi-Med Add Second Chi-Med Drug to Combo Partnership
$5.00
Available
Chengsheng Bio Delisted following Major Vaccine Scandal
$5.00
Available
CTFH and Insilico Form $200 Million AI-Based Drug Discovery Partnership
$5.00
Available
Chi-Med Starts Global Trial of Syk Inhibitor In Lymphoma Patients
$5.00
Available